Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia von Seymour, John F, Kipps, Thomas J, Eichhorst, Barbara, Hillmen, Peter, D’Rozario, James, Assouline, Sarit, Owen, Carolyn, Gerecitano, John, Robak, Tadeusz, De la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Humerickhouse, Rod, Punnoose, Elizabeth A, Li, Yan, Boyer, Michelle, Humphrey, Kathryn, Mobasher, Mehrdad, Kater, Arnon P

Volltext

Pulmonary Artery Pseudoaneurysms: Clinical Features and CT Findings von Chen, Ying, Gilman, Matthew D, Humphrey, Kathryn L, Salazar, Gloria M, Sharma, Amita, Muniappan, Ashok, Shepard, Jo-Anne O, Wu, Carol C

Volltext

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of th... von Kater, Arnon P, Seymour, John F, Hillmen, Peter, Eichhorst, Barbara, Langerak, Anton W, Owen, Carolyn, Verdugo, Maria, Wu, Jenny, Punnoose, Elizabeth A, Jiang, Yanwen, Wang, Jue, Boyer, Michelle, Humphrey, Kathryn, Mobasher, Mehrdad, Kipps, Thomas J

Volltext

Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables von Roberts, Andrew W., Ma, Shuo, Kipps, Thomas J., Coutre, Steven E., Davids, Matthew S., Eichhorst, Barbara, Hallek, Michael, Byrd, John C., Humphrey, Kathryn, Zhou, Lang, Chyla, Brenda, Nielsen, Jacqueline, Potluri, Jalaja, Kim, Su Young, Verdugo, Maria, Stilgenbauer, Stephan, Wierda, William G., Seymour, John F.

Volltext

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study von Kater, Arnon P, Wu, Jenny Qun, Kipps, Thomas, Eichhorst, Barbara, Hillmen, Peter, D'Rozario, James, Assouline, Sarit, Owen, Carolyn, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Dubois, Julie, Eldering, Eric, Mellink, Clemens, Van Der Kevie-Kersemaekers, Anne-Marie, Kim, Su Young, Chyla, Brenda, Punnoose, Elizabeth, Bolen, Christopher R, Assaf, Zoe June, Jiang, Yanwen, Wang, Jue, Lefebure, Marcus, Boyer, Michelle, Humphrey, Kathryn, Seymour, John F

Volltext

Addition of tomosynthesis to conventional digital mammography: effect on image interpretation time of screening examinations von Dang, Pragya A, Freer, Phoebe E, Humphrey, Kathryn L, Halpern, Elkan F, Rafferty, Elizabeth A

Volltext

Venetoclax and obinutuzumab in chronic lymphocytic leukemia von Fischer, Kirsten, Al-Sawaf, Othman, Fink, Anna-Maria, Dixon, Mark, Bahlo, Jasmin, Warburton, Simon, Kipps, Thomas J., Weinkove, Robert, Robinson, Sue, Seiler, Till, Opat, Stephen, Owen, Carolyn, López, Javier, Humphrey, Kathryn, Humerickhouse, Rod, Tausch, Eugen, Frenzel, Lukas, Eichhorst, Barbara, Wendtner, Clemens-M., Stilgenbauer, Stephan, Langerak, Anton W., van Dongen, Jacque J.M., Böttcher, Sebastian, Ritgen, Matthias, Goede, Valentin, Mobasher, Mehrdad, Hallek, Michael

Volltext

Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma von Song, Yu-Qin, Zhang, Hui-Lai, Huang, Hui-Qiang, Zhang, Qing-Yuan, Jing, Hong-Mei, Wang, Chao, Wu, Chun, Li, Dong-Hang, Dai, Yu, Humphrey, Kathryn, Zhu, Jun

Volltext

The impact of early discontinuation/dose modification of venetoclax on outcomes in patients with relapsed/refractory chronic lymphocytic leukemia: post-hoc analyses from the phase... von Mato, Anthony R, Sharman, Jeff P, Biondo, Juliana M L, Wu, Mei, Mun, Yong, Kim, Su Y, Humphrey, Kathryn, Boyer, Michelle, Zhu, Qian, Seymour, John F

Volltext

To do or not to do: axillary nodal evaluation after ACOSOG Z0011 Trial von Humphrey, Kathryn L, Saksena, Mansi A, Freer, Phoebe E, Smith, Barbara L, Rafferty, Elizabeth A

Volltext

Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma von Kim, Eugene, Jiang, Yanwen, Xu, Tao, Bazeos, Alexandra, Knapp, Andrea, Bolen, Christopher R, Humphrey, Kathryn, Nielsen, Tina G, Penuel, Elicia, Paulson, Joseph N

Volltext

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients von Bloehdorn, Johannes, Krzykalla, Julia, Holzmann, Karlheinz, Gerhardinger, Andreas, Jebaraj, Billy Michael Chelliah, Bahlo, Jasmin, Humphrey, Kathryn, Tausch, Eugen, Robrecht, Sandra, Mertens, Daniel, Schneider, Christof, Fischer, Kirsten, Hallek, Michael, Döhner, Hartmut, Benner, Axel, Stilgenbauer, Stephan

Volltext

Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma von Izutsu, Koji, Yamamoto, Kazuhito, Kato, Koji, Ishikawa, Takayuki, Fukuhara, Noriko, Terui, Yasuhito, Choi, Ilseung, Humphrey, Kathryn, Kim, Su Young, Okubo, Sumiko, Ogawa, Natsumi, Nishimura, Yasuko, Salem, Ahmed Hamed, Maruyama, Dai

Volltext

Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440) von Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara, Kozloff, Mark F., Giever, Thomas, Lozanski, Gerard, Jiang, Yanwen, Huang, Huang, Pignataro, Daniela Soriano, Schary, William, Humphrey, Kathryn, Mobasher, Mehrdad, Salles, Gilles

Volltext

Percutaneous breast biopsy: effect on short-term quality of life von Humphrey, Kathryn L, Lee, Janie M, Donelan, Karen, Kong, Chung Y, Williams, Olubunmi, Itauma, Omosalewa, Halpern, Elkan F, Gerade, Beverly J, Rafferty, Elizabeth A, Swan, J Shannon

Volltext

Four-Year Analysis of Murano Study Confirms Sustained Benefit of Time-Limited Venetoclax-Rituximab (VenR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) von Seymour, John F., Kipps, Thomas J., Eichhorst, Barbara F., Hillmen, Peter, D'Rozario, James, Assouline, Sarit, Owen, Carolyn, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Lamanna, Nicole, Kim, Su Young, Wu, Jenny, Jiang, Yanwen, Wang, Jue, Lefebure, Marcus, Boyer, Michelle, Humphrey, Kathryn, Kater, Arnon P

Volltext

Outcome of recommendations for radiographic follow-up of pneumonia on outpatient chest radiography von Little, Brent P, Gilman, Matthew D, Humphrey, Kathryn L, Alkasab, Tarik K, Gibbons, Fiona K, Shepard, Jo-Anne O, Wu, Carol C

Volltext

P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY von Hutchings, Martin, Carlo‐Stella, Carmelo, Morschhauser, Franck, Dickinson, Michael, Bachy, Emmanuel, Cartron, Guillaume, Khan, Cyrus, Tani, Monica, Martinez‐Lopez, Joaquín, Bartlett, Nancy L., Salar, Antonio, Brody, Joshua, Leppa, Sirpa, Baumlin, Pauline, Lundberg, Linda, Relf, James, Xie, Yuying, Bottos, Alessia, Humphrey, Kathryn, Falchi, Lorenzo

Volltext

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma von Dickinson, Michael J., Carlo-Stella, Carmelo, Morschhauser, Franck, Bachy, Emmanuel, Corradini, Paolo, Iacoboni, Gloria, Khan, Cyrus, Wróbel, Tomasz, Offner, Fritz, Trněný, Marek, Wu, Shang-Ju, Cartron, Guillaume, Hertzberg, Mark, Sureda, Anna, Perez-Callejo, David, Lundberg, Linda, Relf, James, Dixon, Mark, Clark, Emma, Humphrey, Kathryn, Hutchings, Martin

Volltext

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions von Goede, Valentin, Fischer, Kirsten, Busch, Raymonde, Engelke, Anja, Eichhorst, Barbara, Wendtner, Clemens M, Chagorova, Tatiana, de la Serna, Javier, Dilhuydy, Marie-Sarah, Illmer, Thomas, Opat, Stephen, Owen, Carolyn J, Samoylova, Olga, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Döhner, Hartmut, Langerak, Anton W, Ritgen, Matthias, Kneba, Michael, Asikanius, Elina, Humphrey, Kathryn, Wenger, Michael, Hallek, Michael

Volltext